EANS-News: Epigenomics AG Licenses Biomarker for Colorectal Cancer Blood Test Screening to Canadian Warnex Medical Laboratories
Warnex to offer a laboratory-developed blood testing service based on Epigenomics' Septin9 Biomarker Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Licensing Agreements/Molecular diagnostics Subtitle: Warnex to offer a ...